Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Yarrow Bioscience, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +12 vs. Q3 2023
- Shares held
- 7.90M
- +7.52M (+1,959.6%) vs. Q3 2023
- Total value
- $18.4M
- +$16.9M (+1,094.7%) vs. Q3 2023
- New holders
- 13
- 9 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eventide Asset Management, LLC | 1,394,336 | $3.25M | 0.05% | +1,394,336 | New |
| Cormorant Asset Management, LP | 1,394,336 | $3.25M | 0.16% | +1,394,336 | New |
| Citadel Advisors LLC | 1,181,088 | $2.75M | 0.00% | +1,181,088 | New |
| Soleus Capital Management, L.P. | 703,868 | $1.64M | 0.18% | +703,868 | New |
| Parkman Healthcare Partners LLC | 696,470 | $1.62M | 0.23% | +696,470 | New |
| DSC Advisors, L.P. | 696,465 | $1.62M | 2.75% | +581,465+505.6% | Added |
| AlphaCentric Advisors LLC | 668,151 | $1.56M | 1.04% | +668,151 | New |
| Palo Alto Investors LP | 445,434 | $1.04M | 0.09% | +445,434 | New |
| Prelude Capital Management, LLC | 118,100 | $275.2K | 0.02% | +118,100 | New |
| Exome Asset Management LLC | 118,100 | $275.2K | 0.27% | +118,100 | New |
| Geode Capital Management, LLC | 94,343 | $219.8K | 0.00% | +66,809+242.6% | Added |
| Susquehanna International Group, LLP | 60,323 | $140.6K | 0.00% | −15,448−20.4% | Reduced |
| Fred Alger Management, LLC | 60,055 | $139.9K | 0.00% | +60,055 | New |
| Vanguard Group Inc | 49,582 | $115.5K | 0.00% | +4,687+10.4% | Added |
| BlackRock Inc. | 47,297 | $110.2K | 0.00% | +2,358+5.2% | Added |
| Renaissance Technologies LLC | 46,376 | $108.0K | 0.00% | +20,400+78.5% | Added |
| Northern Trust Corp | 36,951 | $86.1K | 0.00% | +36,951 | New |
| Staley Capital Advisers Inc | 36,472 | $85.0K | 0.00% | +13,000+55.4% | Added |
| Millennium Management LLC | 17,273 | $40.2K | 0.00% | +17,273 | New |
| State Street Corp | 11,665 | $27.2K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 10,043 | $23.0K | 0.00% | +10,043 | New |
| US Bancorp | 4,444 | $10.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,785 | $6.49K | 0.00% | −638−18.6% | Reduced |
| Morgan Stanley | 1,868 | $4.35K | 0.00% | −311−14.3% | Reduced |
| Royal Bank of Canada | 1,265 | $3.00K | 0.00% | −930−42.4% | Reduced |
| MB, Levis & Associates, LLC | 1,041 | $2.43K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 846 | $1.97K | 0.00% | +662+359.8% | Added |
| Tower Research Capital LLC (TRC) | 790 | $1.84K | 0.00% | +521+193.7% | Added |
| Russell Investments Group, Ltd. | 187 | $435 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 172 | $400 | 0.00% | +67+63.8% | Added |
| JPMorgan Chase & Co | 146 | $341 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 22 | $51 | 0.00% | 00.0% | Unchanged |
| Indiana Trust & Investment Management CO | 12 | $28 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −127−100.0% | Sold out |